I've reviewed the content and it appears to be quite comprehensive. However, I'll make a few minor enhancements to ensure completeness and clarity:

Pompe

Disease Overview

Pompe disease is a rare genetic disorder characterized by the progressive accumulation of glycogen in various tissues and organs, particularly muscles, due to a deficiency of the enzyme acid alpha-glucosidase (GAA). This accumulation leads to significant cellular dysfunction and progressive damage.

Disease Category

Lysosomal Storage Disorder
Metabolic Muscle Disease (Myopathy)
Genetic Disorder
Autosomal Recessive Inheritance

Synonyms

Glycogen Storage Disease Type II (GSD II)
Acid Maltase Deficiency (AMD)
Glycogenosis Type II
Acid α-Glucosidase Deficiency

Signs & Symptoms

Symptoms vary by disease onset:

Infantile-Onset Pompe Disease: - Severe muscle weakness - Hypotonia (low muscle tone) - Hepatomegaly (enlarged liver) - Cardiomegaly (enlarged heart) - Respiratory insufficiency - Feeding difficulties - Failure to thrive - Potential cardiac and respiratory failure

Late-Onset Pompe Disease: - Progressive muscle weakness - Respiratory complications - Fatigue - Muscle pain - Difficulty walking - Potential respiratory muscle involvement - Reduced exercise tolerance

Causes

Genetic mutations in the GAA gene
Autosomal recessive inheritance pattern
Reduced or absent acid alpha-glucosidase (GAA) enzyme activity
Impaired glycogen breakdown in lysosomes
Progressive glycogen accumulation in cells

Affected Populations

Incidence: Approximately 1 in 40,000 for infantile-onset
Incidence: Approximately 1 in 57,000 for late-onset
Affects all ethnic groups
No significant gender predilection

Disorders with Similar Symptoms

Muscular Dystrophies
McArdle's Disease
Other Glycogen Storage Diseases
Congenital Myopathies
Limb-Girdle Muscular Dystrophies

Diagnosis

Diagnostic Methods: - Enzyme activity assay - Genetic mutation analysis - Muscle biopsy - Electromyography (EMG) - Echocardiogram - Creatine kinase (CK) level testing - Pulmonary function tests

Standard Therapies

Enzyme Replacement Therapy (ERT)
Alglucosidase alfa administration
Respiratory support
Physical therapy
Nutritional management
Orthopedic interventions
Respiratory assistive devices

Clinical Trials and Studies

Ongoing research in gene therapy
Next-generation enzyme replacement strategies
Substrate reduction therapies
Chaperone therapies
Stem cell research

References

National Organization for Rare Disorders (NORD)
Genetics Home Reference
National Institute of Neurological Disorders and Stroke
Orphanet Journal of Rare Diseases

Programs & Resources

Acid Maltase Deficiency Association (AMDA)
International Pompe Association
Muscular Dystrophy Association
National Institutes of Health Rare Diseases Clinical Research Network

Complete Report

A comprehensive overview of a complex genetic disorder involving progressive glycogen accumulation, with variable onset and significant clinical implications requiring multidisciplinary management and ongoing research.

The restructured document maintains the original content while providing a more structured and comprehensive presentation of Pompe disease information.